Iatrogenic cardiac perforation due to pacemaker and defibrillator leads: a contemporary multicentre experience. Issue 11 (27th July 2022)

• Record Type: Journal Article
• Authors: Waddingham, Peter H; Elliott, James; Bates, Alexander; Bilham, James; Muthumala, Amal; Honarbakhsh, Shohreh; Ullah, Waqas; Hunter, Ross J; Lambiase, Pier D; Lane, Rebecca E; Chow, Anthony W C
• Is Part Of: Europace. Volume 24:Issue 11(2022)
• Page Start: 1824
• Page End: 1833
• Publication Date: 2022-07-27
• Subjects: Cardiac perforation -- Pacemaker -- Defibrillator -- Lead -- Pericardial effusion -- Tamponade; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euac105
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: To determine the incidence, clinical features, management, and outcomes of pacemaker (PM) and implantable cardioverter-defibrillator (ICD) lead cardiac perforation. Cardiac perforations due to PM and ICD leads are rare but serious complications. Clinical features vary widely and may cause diagnostic delay. Management strategies are non-guideline based due to paucity of data. Methods and results: A multicentre retrospective series including 3 UK cardiac tertiary centres from 2016 to 2020. Patient, device, and lead characteristics were obtained including 6-month outcomes. Seventy cases of perforation were identified from 10 631 procedures; perforation rate was 0.50% for local implants. Thirty-nine (56%) patients were female, mean ( ± standard deviation) age 74 ( ± 13.8) years. Left ventricular ejection fraction 51 ( ± 13.2) %. Median time to diagnosis was 9 (range: 0–989) days. Computed tomography (CT) diagnosed perforation with 97% sensitivity. Lead parameter abnormalities were present in 86% (whole cohort) and 98.6% for perforations diagnosed >24 h. Chest pain was the commonest symptom, present in 46%. The management strategy was percutaneous in 98.6% with complete procedural success in 98.6%. Pericardial effusion with tamponade was present in 17% and was associated with significantly increased mortality and major complications. Anticoagulation status was associated with tamponade by multivariate analysis (odds ratio 21.7, 95% confidence interval: 1.7–275.5, P = 0.018). Conclusions: Perforation was rare (0.50%) and managed successfully by a percutaneous strategy with good outcomes. Tamponade was associated with increased mortality and major complications. Anticoagulation status was an independent predictor of tamponade. Case complexity is highly variable and requires skilled operators with a multi-disciplinary approach to achieve good outcomes.